Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Neuren Pharmaceuticals Limited (AU:NEU)

ASX:NEU

NEU

Neuren Pharmaceuticals Limited

RESEARCH TOOLSreports

Neuren Pharmaceuticals Limited (NEU) Ratios

Compare

278 Followers

Neuren Pharmaceuticals Limited Ratios

AU:NEU's free cash flow for Q2 2025 was AU$0.47. For the 2025 fiscal year, AU:NEU's free cash flow was decreased by AU$ and operating cash flow was AU$0.39. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	40.42	8.73	5.78	25.77	49.87
Quick Ratio	40.42	8.73	5.78	25.77	49.87
Cash Ratio	0.75	0.07	0.40	23.95	45.81
Solvency Ratio	18.69	3.10	3.67	0.12	-9.70
Operating Cash Flow Ratio	17.36	-0.25	4.32	2.14	-12.42
Short-Term Operating Cash Flow Coverage	0.00	0.00	0.00	0.00	0.00
Net Current Asset Value	AU$ 312.27M	AU$ 353.52M	AU$ 204.39M	AU$ 41.57M	AU$ 39.24M
Leverage Ratios
Debt-to-Assets Ratio	0.00	0.00	0.00	0.00	0.00
Debt-to-Equity Ratio	0.00	0.00	0.00	0.00	0.00
Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	1.02	1.13	1.21	1.04	1.02
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Interest Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Debt to Market Cap	0.00	0.00	0.00	0.00	0.00
Interest Debt Per Share	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-0.03	-0.02	-0.09	25.33	4.47
Profitability Margins
Gross Profit Margin	86.42%	99.99%	88.47%	99.93%	99.75%
EBIT Margin	84.24%	82.32%	85.89%	-11.04%	-343.79%
EBITDA Margin	84.25%	82.33%	85.92%	-10.90%	-257.27%
Operating Profit Margin	70.67%	82.32%	74.37%	-10.97%	-357.52%
Pretax Profit Margin	86.43%	85.79%	88.45%	-4.67%	-343.79%
Net Profit Margin	67.51%	66.61%	67.73%	1.26%	-243.79%
Continuous Operations Profit Margin	67.51%	66.61%	67.73%	1.26%	-243.79%
Net Income Per EBT	78.12%	77.64%	76.57%	-27.06%	70.91%
EBT Per EBIT	122.31%	104.21%	118.93%	42.61%	96.16%
Return on Assets (ROA)	45.00%	34.67%	63.35%	0.43%	-19.46%
Return on Equity (ROE)	43.38%	39.03%	76.55%	0.44%	-19.86%
Return on Capital Employed (ROCE)	48.25%	48.24%	84.06%	-3.84%	-29.12%
Return on Invested Capital (ROIC)	37.69%	37.45%	64.37%	1.04%	-20.65%
Return on Tangible Assets	45.00%	34.67%	63.35%	0.43%	-19.46%
Earnings Yield	6.92%	8.89%	4.98%	0.02%	-1.76%
Efficiency Ratios
Receivables Turnover	10.76	1.23	16.09	13.36	2.25
Payables Turnover	4.50	0.02	39.63	0.04	0.03
Inventory Turnover	0.00	0.00	0.00	0.00	8.00K
Fixed Asset Turnover	8.83K	6.88K	5.39K	693.00	266.42
Asset Turnover	0.67	0.52	0.94	0.34	0.08
Working Capital Turnover Ratio	0.66	0.76	1.89	0.36	0.10
Cash Conversion Cycle	-47.20	-23.74K	13.47	-9.39K	-11.02K
Days of Sales Outstanding	33.93	295.96	22.68	27.31	162.58
Days of Inventory Outstanding	0.00	0.00	0.00	0.00	0.05
Days of Payables Outstanding	81.13	24.04K	9.21	9.42K	11.18K
Operating Cycle	33.93	295.96	22.68	27.31	162.62
Cash Flow Ratios
Operating Cash Flow Per Share	1.07	-0.09	1.46	0.03	-0.08
Free Cash Flow Per Share	1.07	-0.09	1.45	0.03	-0.08
CapEx Per Share	<0.01	<0.01	<0.01	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	1.00	1.00	1.00	0.99	1.00
Dividend Paid and CapEx Coverage Ratio	11.47K	-1.13K	4.62K	189.42	-997.00
Capital Expenditure Coverage Ratio	11.47K	-1.13K	4.62K	189.42	-997.00
Operating Cash Flow Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Sales Ratio	0.62	-0.05	0.80	0.25	-3.12
Free Cash Flow Yield	6.51%	-0.71%	5.86%	0.36%	-2.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	14.45	11.24	20.08	5.44K	-56.97
Price-to-Sales (P/S) Ratio	9.57	7.49	13.60	68.81	138.88
Price-to-Book (P/B) Ratio	6.66	4.39	15.37	24.08	11.31
Price-to-Free Cash Flow (P/FCF) Ratio	15.37	-141.59	17.06	279.73	-44.49
Price-to-Operating Cash Flow Ratio	15.65	-141.71	17.05	278.25	-44.53
Price-to-Earnings Growth (PEG) Ratio	2.67	-1.07	<0.01	-53.22	2.48
Price-to-Fair Value	6.66	4.39	15.37	24.08	11.31
Enterprise Value Multiple	11.33	9.08	15.74	-606.08	-49.51
Enterprise Value	2.11B	1.59B	3.14B	961.25M	407.21M
EV to EBITDA	11.33	9.08	15.74	-606.08	-49.51
EV to Sales	9.55	7.47	13.52	66.05	127.37
EV to Free Cash Flow	15.32	-141.31	16.97	268.50	-40.80
EV to Operating Cash Flow	15.32	-141.43	16.96	267.09	-40.84
Tangible Book Value Per Share	2.51	2.85	1.61	0.33	0.33
Shareholders’ Equity Per Share	2.51	2.85	1.61	0.33	0.33
Tax and Other Ratios
Effective Tax Rate	0.22	0.22	0.23	1.27	0.29
Revenue Per Share	1.71	1.67	1.83	0.12	0.03
Net Income Per Share	1.16	1.11	1.24	<0.01	-0.07
Tax Burden	0.78	0.78	0.77	-0.27	0.71
Interest Burden	1.03	1.04	1.03	0.42	1.00
Research & Development to Revenue	0.14	0.15	0.12	0.87	2.98
SG&A to Revenue	0.02	0.02	0.03	0.24	0.60
Stock-Based Compensation to Revenue	<0.01	0.00	0.00	0.14	0.26
Income Quality	0.92	-0.08	1.18	19.56	1.28

Currency in AUD